Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Centessa Pharmaceuticals logo

Centessa Pharmaceuticals

Recent Finacing

Series A

Recent Raise

$250M

Centessa runs an asset-centric R&D platform of autonomous biotech subsidiaries advancing 15 programs across oncology, hematology, immunology, inflammation, neuroscience, rare diseases, backed by centralized discovery, manufacturing and regulatory support.

Founded 2021
Massachusetts, United States
51-100
Publicly Traded
centessa.com

Highlights

Focus Areas

Biotechnology
Pharmaceutical

Recent Investors

Janus Henderson Investors logo
LifeSci Venture Partners logo
EcoR1 Capital logo
Wellington Management logo
Franklin Templeton logo
T. Rowe Price Associates logo
Samsara BioCapital logo
Logos Capital logo
BVF Partners logo
Boxer Capital logo
General Atlantic logo
Cormorant Asset Management logo

Financials

$250M

Total Raised

1

Funding round

14

Investors


Team

Upgrade to view the team

See the team members at Centessa Pharmaceuticals.